PM360 2018 Trailblazer Awards Dermatology Brand Champion Sandy Sexton

Sandy Sexton, Director, Consumer Marketing, Regeneron Healthcare Solutions

While some people may think eczema is just a rash, they would be wrong. Nearly eight million adults in the U.S. live with eczema, and 1.6 million of them live with uncontrolled moderate-to-severe eczema (atopic dermatitis). The rashes are just the visible signs. As a member of the DUPIXENT® (dupilumab) co-promote team, composed of professionals from Regeneron and Sanofi Genzyme, Sandy Sexton has been dedicated to ensuring education and support is available for patients with moderate-to-severe atopic dermatitis.

DUPIXENT is the first treatment specifically for those living with uncontrolled moderate-to-severe atopic dermatitis, and to get the word out Sandy’s team released a battery of different branded and disease education tactics—all of which involved patients in a meaningful way. They also enlisted the help of Snow Companies to launch two phases of Patient Ambassador® programs.

Phase one consists of a disease awareness program in which participants share their real-life experiences on all disease awareness platforms, including This group of Patient Ambassadors will continue to educate HCPs, patients, and other stakeholders about the relevance of the issue throughout 2018. The second phase will consist of a branded program, which will launch later this year, to educate the audience about an underlying cause of atopic dermatitis.

So far, numerous patients and caregivers have been overwhelmed by the support and motivation they gained from being involved in Sandy’s team’s programs. “There is nothing like meeting and speaking to others who know from firsthand experience what it’s like,” says Anthony, DUPIXENT MyWay® Ambassador. “It’s an incredible feeling to be validated and vindicated.”


You May Also Like

PM360 2021 Trailblazer Awards Marketing Team of the Year Gold Winner ENSPRYNG Launch Team

ENSPRYNG Launch Team Genentech Agency Partners: Intouch Group, VMLY&R, Heartbeat, SNOW Companies, and CMI ...

Breaking the Mold—the 2017 Pharma Choice Awards Winners!

Groundbreaking. Empathetic. Creative. These are just a few of the qualities that define the ...

PM360 2020 Innovative Company LightDeck Diagnostics

LightDeck Diagnostics Kathryn Ryan, PR representative LightDeck Diagnostics is dedicated to a new ...